Join
Live feed
·
INSIDERFilingvia Quantisnow
Krystal Biotech Inc. logo

President, R&D Krishnan Suma sold $8,982,986 worth of shares (25,000 units at $359.32) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,302,145 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KRYS· Krystal Biotech Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRYS (Krystal Biotech Inc.) and more on Quantisnow.